(KPT) KP Tissue - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA48265Y1043
KPT EPS (Earnings per Share)
KPT Revenue
KPT: Tissues, Paper Towels, Napkins
KP Tissue Inc. is a Canadian company that produces and distributes a range of disposable tissue products through its interest in Kruger Products Inc. With a presence in both Canada and the United States, the company operates through two main segments: Consumer and Away-From-Home. Its product portfolio includes bathroom and facial tissues, paper towels, and napkins, marketed under various brand names such as Cashmere, Scotties, and Purex, as well as private labels. The companys diverse brand portfolio and geographic presence provide a stable foundation for revenue generation.
The tissue products industry is generally characterized by steady demand, driven by consumer essentials, and KP Tissue Inc. is well-positioned within this market. Given its established brand names and distribution networks, the company has the potential to maintain its market share and potentially expand through strategic initiatives. The Away-From-Home segment, in particular, presents opportunities for growth as it caters to commercial and institutional clients, which can provide a relatively stable source of revenue.
Analyzing the provided
From a fundamental perspective, KP Tissue Inc. has a Market Cap of $86.19M CAD, a P/E ratio of 35.96, and a Forward P/E of 31.95. The Return on Equity (RoE) stands at 3.44%. While the P/E ratios may suggest that the stock is relatively expensive, the companys stable industry position and potential for growth through its diversified segments could justify the valuation. The relatively low RoE might indicate areas for operational improvement or potential for increased profitability through strategic initiatives.
Forecasting future performance, the positive trend indicated by the technical data, combined with the companys stable industry position and potential for growth, suggests that KP Tissue Inc. could continue to perform well. If the company can maintain its current trend and potentially improve its operational efficiency to enhance profitability, the stock could see further gains. A potential target could be a price level above its current 52-week high, driven by sustained demand for its products and successful execution of its business strategy. However, investors should closely monitor the companys financial performance and industry trends to adjust their expectations accordingly.
Additional Sources for KPT Stock
KPT Stock Overview
Market Cap in USD | 67m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Personal Care Products |
IPO / Inception |
KPT Stock Ratings
Growth Rating | 11.7 |
Fundamental | 15.7 |
Dividend Rating | 63.3 |
Rel. Strength | 2.3 |
Analysts | - |
Fair Price Momentum | 9.31 CAD |
Fair Price DCF | 3.66 CAD |
KPT Dividends
Dividend Yield 12m | 8.35% |
Yield on Cost 5y | 9.68% |
Annual Growth 5y | 0.00% |
Payout Consistency | 95.4% |
Payout Ratio | 108.1% |
KPT Growth Ratios
Growth Correlation 3m | 98% |
Growth Correlation 12m | 23.7% |
Growth Correlation 5y | -4.2% |
CAGR 5y | 4.18% |
CAGR/Max DD 5y | 0.16 |
Sharpe Ratio 12m | -0.28 |
Alpha | 12.67 |
Beta | 0.129 |
Volatility | 12.45% |
Current Volume | 32k |
Average Volume 20d | 11.4k |
As of July 01, 2025, the stock is trading at CAD 9.28 with a total of 32,032 shares traded.
Over the past week, the price has changed by +1.97%, over one month by +5.50%, over three months by +19.33% and over the past year by +18.26%.
Neither. Based on ValueRay´s Fundamental Analyses, KP Tissue is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 15.71 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of KPT is around 9.31 CAD . This means that KPT is currently overvalued and has a potential downside of 0.32%.
KP Tissue has no consensus analysts rating.
According to our own proprietary Forecast Model, KPT KP Tissue will be worth about 10.1 in July 2026. The stock is currently trading at 9.28. This means that the stock has a potential upside of +8.62%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 9.4 | 1.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 10.1 | 8.6% |